Image de couverture de livre

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Serena Laura Orr, Jonathan Kuziek, Samina Ali, Eva Anderson, Kathryn A. Birnie, Andrew D. Hershey, Prachi Khanna, Adam Kirton, Tolulope Sajobi, Stephen B. Freedman
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Headache: The Journal of Head and Face Pain
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
par: Rebecca Lindsay, et autres
Publié: (2024)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
par: Jennifer Robblee, et autres
Publié: (2026)

Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence‐based care for migraine in the emergency department
par: Serena L. Orr
Publié: (2026)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
par: Bilal Ahmed Rizvi, et autres
Publié: (2024)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
par: Alexis Espanioli, et autres
Publié: (2025)

Maternal and child mental health and incident migraine in adolescence: An “All Our Families” prospective cohort study
par: Kirsten Sjonnesen, et autres
Publié: (2026)

Parental mental health and migraine in youth: An evolving story historically plagued with sparse and inadequate literature and mother‐blaming
par: Serena L. Orr
Publié: (2024)

Evaluating patient and family preferences for acute and preventive pediatric headache treatment
par: Elise G. Martin, et autres
Publié: (2024)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
par: Marina Vives‐Mestres, et autres
Publié: (2024)

Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon
par: Stephanie J. Nahas, et autres
Publié: (2025)

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2025)

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
par: Nan Cheng, et autres
Publié: (2025)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
par: Yunus Emre Meydanal, et autres
Publié: (2025)

Useful considerations for treating migraine in patients with autism
par: Sinifunanya E. Nwaobi
Publié: (2026)

A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth
par: Carlyn Patterson Gentile, et autres
Publié: (2024)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
par: Amy A. Gelfand
Publié: (2024)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
par: Brooke L. Reidy, et autres
Publié: (2025)

Response to: Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
par: Christina Murphy, et autres
Publié: (2025)

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update
par: Andrew C. Charles, et autres
Publié: (2024)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
par: Irene Patniyot, et autres
Publié: (2024)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
par: M. Ismail K. Yousaf, et autres
Publié: (2025)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
par: Geneviève Tourigny‐Ruel, et autres
Publié: (2026)

Rising migraine incidence in adolescents despite stable prevalence in the US : A call for further investigation
par: Ali Reza Tavasoli, et autres
Publié: (2024)

Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
par: Matteo Conti, et autres
Publié: (2024)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
par: Todd J. Schwedt, et autres
Publié: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
par: Muneto Tatsumoto, et autres
Publié: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
par: Graham A. McLeod, et autres
Publié: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
par: Joanna K. Bougie, et autres
Publié: (2024)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
par: Nathaniel M. Schuster, et autres
Publié: (2025)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
par: Luana Miyahira Makita, et autres
Publié: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
par: Koichi Ikeda, et autres
Publié: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
par: Rikki Mangrum, et autres
Publié: (2024)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
par: Charly Gaul, et autres
Publié: (2025)

Evaluating associations of migraine‐related vertigo
par: Nazia Karsan, et autres
Publié: (2025)

Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study
par: Carlyn Patterson Gentile, et autres
Publié: (2024)

Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Association: A pilot project
par: Larry Charleston
Publié: (2024)

Afterimage duration differs for migraine with or without aura
par: Florian Rimmele, et autres
Publié: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
par: Rebecca Erwin Wells, et autres
Publié: (2024)